Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes
Patient and physician characteristics associated with use of erythropoiesis-stimulating agents in myelodysplastic syndrome patients have not yet been described. Myelodysplastic syndrome patients diagnosed from 2001 to 2005 were identified from the Surveillance Epidemiology and End Results-Medicare d...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2012-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/6175 |